New test could predict life-threatening side effects of cancer immunotherapy

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs.

Use of Home-Based OCT for Neovascular AMD Could Lead to More Timely Treatment

A retrospective review of home-based optical coherence tomography (OCT) monitoring for neovascular age-related macular degeneration (AMD) found that treatment should have been performed earlier in

November 22, 2024

How maternal diet composition influences offspring appetite and metabolic health

Researchers evaluated the impact of maternal dietary protein and carbohydrate balance on offspring’s appetite and metabolic health.

February 15, 2024

Accord BioPharma’s HERCESSI gets FDA approval

HERCESSI is approved for treating HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric or gastroesophageal junction adenocarcinoma. Credit: Lightspring/Shutterstock. Accord BioPharma, the speciality division

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.